Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104 (Liafensine...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2376134308

Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104 (Liafensine) for Depression: Potential First Pharmagenomic Biomarker in Neurological Diseases

About this item

Full title

Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104 (Liafensine) for Depression: Potential First Pharmagenomic Biomarker in Neurological Diseases

Publisher

New York: PR Newswire Association LLC

Journal title

PR Newswire, 2020

Language

English

Formats

Newsletter articles

Publication information

Publisher

New York: PR Newswire Association LLC

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104 (Liafensine) for Depression: Potential First Pharmagenomic Biomarker in Neurological Diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2376134308

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2376134308

How to access this item

Log in as a Library member

View record in ProQuest

View in old catalogue

Connecting people and collections

Indigenous engagement

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Schools and teachers

Learning programs and resources linked to the curriculum.

Stories

Showcasing people, places and ideas inspired by the collection and the library community.